FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis
Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely active ulcerative colitis.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Ulcerative Colitis